Venture Outlook 2020

Speakers

  • Allison Long Pettine
    Allison Long Pettine
    Investor & Co-founder, Ad Astra Ventures

    Allison Long Pettine is an investor and entrepreneur who is passionate about finding and empowering visionaries uniquely destined to change the world. She recently founded Ad Astra Ventures, a business accelerator dedicated to empowering founders of high growth startups with at least one female cofounder. She is President of Crescent Ridge Partners, Founding Partner at SEED San Diego, and co-founder of Lymber, which was sold to MindBody in 2017. Allison began her career at Viscogliosi Brothers, a New-York based venture capital company focused on cutting-edge orthopedic medical device technologies. She was an early employee and Director of Corporate Finance and Strategic Planning at Paradigm Spine, a startup that developed non-fusion spinal implants to treat degenerative and deformity spinal disorders. Allison is a mentor at Tech Stars, sits on the advisory board of UCSD’s The Basement incubator, sits on the board of the San Diego Venture Group and is a committee member at San Diego’s Evo Nexus incubator.

  • Bobby Franklin
    Bobby Franklin
    President & CEO, National Venture Capital Association

    Bobby Franklin is the President & CEO of the National Venture Capital Association (NVCA) whose membership includes hundreds of venture capital firms and thousands of individuals that invest in the entrepreneurial ecosystem. With over 25 years of experience in advocacy and public policy in our nation’s capital, Bobby took the helm of NVCA in September of 2013 after nearly a decade at CTIA – The Wireless Association, where he first served as head lobbyist and then spent the next eight years as the association’s Executive Vice President.
    Prior to joining CTIA, Bobby worked for wireless provider Alltel Corporation as both their lobbyist and then head of the company’s Washington office. An Arkansas native, Bobby got his start in Washington working in the U.S. Senate for Senator David Pryor of Arkansas.

  • David Coats
    David Coats
    Partner, Correlation Ventures

    As a founder and Managing Director of Correlation Ventures, David helps lead the firm. David created the original vision for Correlation, driven by the opportunity to offer entrepreneurs and other VCs a better co-investment option and to pioneer the use of predictive analytics in venture capital. David began his venture capital career in 1997. Prior to Correlation, David was a Managing Director of Hamilton BioVentures, an early-stage venture capital fund. As head of Hamilton’s Life Science team, David served on the Board of Directors of such companies as PhotoThera, Transcept (NASDAQ: TSPT), and Egea Biopharmaceuticals (Acquired by Johnson&Johnson). Previously, David was a Venture Partner at Windamere Venture Partners and President of Forge Medical Ventures, an early-stage incubator funded by Enterprise Partners, Mayfield Fund and Johnson & Johnson Development Corporation. David was the Founder of Spine Wave, a venture-funded medical device company and Director of Business Development of UroMed Corporation (URMD), a venture-funded startup that raised several rounds of venture capital and completed a public offering.

JLabs

Location

JLabs
3210 Merryfield Row, San Diego, CA 92121
Category

More Info

Register
QR Code

Date

Feb 11 2020

Time

4:30 pm - 6:30 pm

Venture Outlook 2020

Venture Outlook 2020
Join us to discuss the venture landscape in 2020 and review San Diego, SoCal, and national data.

Presentations from CEO and President of the National Venture Capital Association, Bobby Franklin, and local data source and expert with Correlation Ventures, David Coats — followed with a fireside chat moderated by local investor and startup resource, Co-founder of Ad Astra Ventures, Allison Long Pettine.

Learn about the current venture landscape from two different expert viewpoints.

National Venture Outlook Association (NVCA) Correlation Ventures

Hourly Schedule

Venture Outlook 2020

4:30pm - 5:30pm
Networking
Refreshments provided
5:30pm - 6:30pm
Program
Presentation of past trends and projections from CEO and President of the National Venture Capital Association, Bobby Franklin, and local data source and expert with Correlation Ventures, David Coats
Speakers:
Bobby Franklin, David Coats
Bobby Franklin
Bobby Franklin
President & CEO, National Venture Capital Association
Bobby Franklin is the President & CEO of the National Venture Capital Association (NVCA) whose membership includes hundreds of venture capital firms and thousands of individuals that invest in the entrepreneurial ecosystem. With over 25 years of experience in advocacy and public policy in our nation’s capital, Bobby took the helm of NVCA in September of 2013 after nearly a decade at CTIA – The Wireless Association, where he first served as head lobbyist and then spent the next eight years as the association’s Executive Vice President. Prior to joining CTIA, Bobby worked for wireless provider Alltel Corporation as both their lobbyist and then head of the company’s Washington office. An Arkansas native, Bobby got his start in Washington working in the U.S. Senate for Senator David Pryor of Arkansas.
David Coats
David Coats
Partner, Correlation Ventures
As a founder and Managing Director of Correlation Ventures, David helps lead the firm. David created the original vision for Correlation, driven by the opportunity to offer entrepreneurs and other VCs a better co-investment option and to pioneer the use of predictive analytics in venture capital. David began his venture capital career in 1997. Prior to Correlation, David was a Managing Director of Hamilton BioVentures, an early-stage venture capital fund. As head of Hamilton’s Life Science team, David served on the Board of Directors of such companies as PhotoThera, Transcept (NASDAQ: TSPT), and Egea Biopharmaceuticals (Acquired by Johnson&Johnson). Previously, David was a Venture Partner at Windamere Venture Partners and President of Forge Medical Ventures, an early-stage incubator funded by Enterprise Partners, Mayfield Fund and Johnson & Johnson Development Corporation. David was the Founder of Spine Wave, a venture-funded medical device company and Director of Business Development of UroMed Corporation (URMD), a venture-funded startup that raised several rounds of venture capital and completed a public offering.